Antigenicity of amino-acid sequences from Clostridium difficile toxin B

Journal of Medical Microbiology

Volumn 44, Issue 6, 1996, Pages 464-474

  Torres, J F ^a,b   Monath, T P ^a  

^a Acambis   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN B; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM DIFFICILE; COLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029980942     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-44-6-464     Document Type: Article

References (36)

1. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun 1985; 47: 349-352.
2. Mitchell TJ, Ketley JM, Haslam SC et al. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut 1986; 27: 78-85.
3. Torres J, Jennische E, Lange S, Lönnroth I. Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine. Gut 1990; 31: 781-785.
4. Hecht G, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 1988; 82: 1516-1524.
5. Flegel WA, Müller F, Däubener W, Fischer H-G, Hadding U, Northoff H. Cytokines response by human monocytes to Clostridium difficile toxin A and toxin B. Infect Immun 1991; 59: 3659-3666.
6. Miller PD, Pothoulakis C, Backer TR, LaMont JT, Rothstein TL. Macrophage-dependent stimulation of T cell-depleted spleen cells by Clostridium difficile toxin A and calcium ionophore. Cell Immunol 1990; 126: 155-163.
7. Malorni W, Paradisi S, Dupuis ML, Fiorentini C, Ramoni C. Enhancement of cell-mediated cytotoxicity by Clostridium difficile toxin A: an in vitro study. Toxicon 1991; 29: 417-428.
8. Pothoulakis C, Sullivan R, Melnick DA et al. Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest 1988; 81: 1741-1745.
9. Pothoulakis C, Karmeli F, Kelly CP et al. Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum. Gastroenterology 1993; 105: 701-707.
10. 84 monolayers. Gastroenterology 1992; 102: 416-423.
11. Siffert JC, Baldacini O, Kuhry JG et al. Effects of Clostridium difficile toxin B on human monocytes and macrophages: possible relationship with cytoskeletal rearrangement. Infect Immun 1993; 61: 1082-1090.
12. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-262.
13. Viscidi R, Laughon BE, Yolken R et al. Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 1983; 148: 93-100.
14. Leung DYM, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991; 118: 633-637.
15. Warny M, Vaerman J-P, Avesani V, Delmée M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994; 62: 384-389.
16. Johnson S, Gerding DN, Janoff EN. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile. J Infect Dis 1992; 166: 1287-1294.
17. Fernie DS, Thomson RO, Batty I, Walker PD. Active and passive immunization to protect against antibiotic associated caecitis in hamsters. Dev Biol Stand 1983; 53: 325-332.
18. Kim P-H, Iaconis JP, Rolfe RD. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987; 55: 2984-2992.
19. Libby JM, Jortner BS, Wilkins TD. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun 1982; 36: 822-829.
20. Ketley JM, Mitchell TJ, Candy DCA, Burdon DW, Stephen J. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits. J Med Microbiol 1987; 24: 41-52.
21. Barroso LA, Wang S-Z, Phelps CJ, Johnson JL, Wilkins TD. Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res 1990; 18: 4004.
22. Dove CH, Wang S-Z, Price SB et al. Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 1990; 58: 480-488.
23. Barroso LA, Moncrief JS, Lyerly DM, Wilkins TD. Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. Microb Pathog 1994; 16: 297-303.
24. von Eichel-Streiber C, Laufenberg-Feldmann R, Sartingen S, Schulze J, Sauerborn M. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol Gen Genet 1992; 233: 260-268.
25. Frey SM, Wilkins TD. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun 1992; 60: 2488-2492.
26. Lyerly DM, Phelps CJ, Toth J, Wilkins TD. Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun 1986; 54: 70-76.
27. Tam JP Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigen peptide system. Proc Natl Acad Sci USA 1988; 85: 5409-5413.
28. Reynolds SR, Dahl CE, Harn DA. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 1994; 152: 193-200.
29. Torres JF, Lönnroth I. Production, purification and characterisation of Clostridium difficile toxic proteins different from toxin A and from toxin B. Biochim Biophys Acta 1989; 998: 151-157.
30. Tam JP, Clavijo P, Lu Y-A, Nussenzweig V, Nussenzweig R, Zavala F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med 1990; 171: 299-306.
31. Coffman RL, Seymour BWP, Lebman DA et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988; 102: 5-28.
32. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
33. Däubener W, Leiser E, von Eichel-Streiber C, Hadding U. Clostridium difficile toxins A and B inhibit human immune response in vitro. Infect Immun 1988; 56: 1107-1112.
34. Emini EA, Jameson BA, Wimmer E. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 1983; 304: 699-703.
35. Lyerly DM, Carrig PE, Wilkins TD. Nonspecific binding of mouse monoclonal antibodies to Clostridium difficile toxins A and B. Curr Microbiol 1989; 19: 303-306.
36. von Eichel-Streiber C, Sauerborn M. Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 1990; 96: 107-113.